Lineage Cell Valuation
| BTX Stock | ILS 218.20 1.20 0.55% |
At this time, the firm appears to be overvalued. Lineage Cell Therapeutics secures a last-minute Real Value of S207.17 per share. The latest price of the firm is S218.2. Our model forecasts the value of Lineage Cell Therapeutics from analyzing the firm fundamentals such as Revenue of 4.99 M, ebitda of (37.2 M), and Price To Book of 1.14 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Lineage Cell's price fluctuation is very steady at this time. Calculation of the real value of Lineage Cell Therapeutics is based on 3 months time horizon. Increasing Lineage Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Lineage Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lineage Stock. However, Lineage Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 218.2 | Real 207.17 | Hype 217.0 | Naive 224.74 |
The real value of Lineage Stock, also known as its intrinsic value, is the underlying worth of Lineage Cell Therapeutics Company, which is reflected in its stock price. It is based on Lineage Cell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Lineage Cell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Lineage Cell Therapeutics helps investors to forecast how Lineage stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lineage Cell more accurately as focusing exclusively on Lineage Cell's fundamentals will not take into account other important factors: Lineage Cell Total Value Analysis
Lineage Cell Therapeutics is currently anticipated to have takeover price of 0 with market capitalization of 512.15 M, debt of 5.09 M, and cash on hands of 27.1 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Lineage Cell fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 512.15 M | 5.09 M | 27.1 M |
Lineage Cell Investor Information
The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Lineage Cell Therapeutics had not issued any dividends in recent years. Lineage Cell Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Lineage Cell Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Lineage suggests not a very effective usage of assets in December.Lineage Cell Profitability Analysis
The company reported the revenue of 4.99 M. Net Loss for the year was (45.99 M) with profit before overhead, payroll, taxes, and interest of 4.69 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lineage Cell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lineage Cell and how it compares across the competition.
About Lineage Cell Valuation
The stock valuation mechanism determines Lineage Cell's current worth on a weekly basis. Our valuation model uses a comparative analysis of Lineage Cell. We calculate exposure to Lineage Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lineage Cell's related companies.BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California. BIOTIME INC operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 76 people.
8 Steps to conduct Lineage Cell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lineage Cell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lineage Cell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Lineage Cell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Lineage Cell's revenue streams: Identify Lineage Cell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Lineage Cell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Lineage Cell's growth potential: Evaluate Lineage Cell's management, business model, and growth potential.
- Determine Lineage Cell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lineage Cell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Lineage Stock analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |